| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |